Monday, February 05, 2018 12:38:16 PM
Shares of Johnson & Johnson (NYSE:JNJ) continue to take it on the chin. The stock is now down from its peak of $148 just two weeks ago to $133.00. There will likely be more downside as big players move to cash in the higher risk market. However, there is huge technical chart support at $126. This is the spot where big money will step up and add heavily for a sharp bounce back higher. Look for this technical chart level to buy.
Gareth Soloway
InTheMoneyStocks
Recent JNJ News
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
